Literature DB >> 29148111

Being overweight or obese as a risk factor for acute liver injury secondary to acute acetaminophen overdose.

Summon Chomchai1, Chulathida Chomchai2.   

Abstract

PURPOSE: Increased incidences of hepatotoxicity have been observed in obese patients with acute acetaminophen overdose. We evaluate whether the status of being overweight or obese is associated with increase in the development of hepatotoxicity and acute liver injury (ALI) in patients with acute acetaminophen overdose.
METHODS: This was a retrospective cohort study comparing the risk of hepatotoxicity and ALI between overweight or obese patients (body mass index [BMI] ≥ 25) and normal BMI patients (BMI ≤ 24.9) presenting with acute acetaminophen overdose at Siriraj Hospital during January 2004 to June 2012. All patients were treated with intravenous N-acetylcysteine. Psi parameters were calculated. High psi was defined as psi of ≥5.0 mM-hour. Data were analyzed using multinomial logistic regressions, odds ratio (OR), stratified OR, and 95% confidence interval (CI).
RESULTS: There were 197 patients who fulfilled the criteria for analysis, 35 (17.8%) were obese, 24 (12.2%) were overweight, and 138 (70%) were normal BMI cases. Hepatotoxicity and ALI developed in 25 (12.7%) and 40 (20.3%) cases, respectively. Multinomial logistic regression revealed that the overweight-obesity status and log10 (psi value) were significant risk factors of ALI, with OR (95% CI) of 2.68 (1.21-5.95) and 1.74 (1.27-2.38), respectively, while only log10 (psi) was a significant risk factor of hepatotoxicity with OR (95% CI) 378.51 (39.49-3627.99). From stratification, overweight-obesity had significant odds ratios for ALI in strata with low acetaminophen concentration, early initiation of N-acetylcysteine and low psi.
CONCLUSION: We conclude that being overweight or obese is an independent risk factor of ALI in acute acetaminophen overdoses.
Copyright © 2017 John Wiley & Sons, Ltd.

Entities:  

Keywords:  N-acetylcysteine; body mass index; fatty liver; hepatitis; pharmacoepidemiology; psi parameter

Mesh:

Substances:

Year:  2017        PMID: 29148111     DOI: 10.1002/pds.4339

Source DB:  PubMed          Journal:  Pharmacoepidemiol Drug Saf        ISSN: 1053-8569            Impact factor:   2.890


  6 in total

1.  Impact of obesity on the toxicity of a multi-ingredient dietary supplement, OxyELITE Pro™ (New Formula), using the novel NZO/HILtJ obese mouse model: Physiological and mechanistic assessments.

Authors:  Charles M Skinner; Isabelle R Miousse; Laura E Ewing; Vijayalakshmi Sridharan; Maohua Cao; Haixia Lin; D Keith Williams; Bharathi Avula; Saqlain Haider; Amar G Chittiboyina; Ikhlas A Khan; Mahmoud A ElSohly; Marjan Boerma; Bill J Gurley; Igor Koturbash
Journal:  Food Chem Toxicol       Date:  2018-09-30       Impact factor: 6.023

2.  Evaluation of Dosing Strategies of N-acetylcysteine for Acetaminophen Toxicity in Patients Greater than 100 Kilograms: Should the Dosage Cap Be Used?

Authors:  Regan A Baum; Jordan A Woolum; Abby M Bailey; Molly M Howell; Kyle A Weant; LeeAnn Geraghty; Sanjay Mohan; Ashley N Webb; Mark K Su; Peter Akpunonu
Journal:  J Med Toxicol       Date:  2021-04-21

3.  Unraveling the effect of intra- and intercellular processes on acetaminophen-induced liver injury.

Authors:  M M Heldring; A H Shaw; J B Beltman
Journal:  NPJ Syst Biol Appl       Date:  2022-08-06

Review 4.  Drug dosing in the critically ill obese patient-a focus on sedation, analgesia, and delirium.

Authors:  Brian L Erstad; Jeffrey F Barletta
Journal:  Crit Care       Date:  2020-06-08       Impact factor: 9.097

5.  Poisoning-related emergency department visits: the experience of a Saudi high-volume toxicology center.

Authors:  Mohammad Ali Alghafees; Abdullah Abdulmonen; Mahmoud Eid; Ghadah Ibrahim Alhussin; Mohammed Qasem Alosaimi; Ghadah Saad Alduhaimi; Mohammed Talal Albogami; Mohammed Alhelail
Journal:  Ann Saudi Med       Date:  2022-02-03       Impact factor: 1.526

6.  Sensitivity of dose-estimations for acute acetaminophen overdose in predicting hepatotoxicity risk using the Rumack-Matthew Nomogram.

Authors:  Summon Chomchai; Pattaraporn Mekavuthikul; Jariya Phuditshinnapatra; Chulathida Chomchai
Journal:  Pharmacol Res Perspect       Date:  2022-02
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.